Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative efficacy of sildenafil and bosentan in newborns with persistent pulmonary hypertension
TCTR20260321006Completed
- Sponsor
- dr. abdul qayuum
- Start
- Sep 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of sildenafil and bosentan in persistent pulmonary hypertension of the newborn (PPHN) (2 arms), sponsored by dr. abdul qayuum. Started Sep 2023; status: completed.
02
Drugs
sildenafilbosentan
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on TCTR20260321006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260321006.